Nice Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.53 M
as on 16-11-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.19 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.40 Cr
as on 16-11-2024
- Revenue -12.02%
(FY 2023)
- Profit 0.06%
(FY 2023)
- Ebitda -2.96%
(FY 2023)
- Net Worth 22.41%
(FY 2023)
- Total Assets 26.65%
(FY 2023)
About Nice Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.53 M.
The company currently has active open charges totaling ₹3.19 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagdeep Singh and Simmi Gujral serve as directors at the Company.
- CIN/LLPIN
U24232DL2009PTC193907
- Company No.
193907
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nice Pharmaceuticals Private Limited offer?
Nice Pharmaceuticals Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Care Products, Ayurvedic & Herbal Health Supplement, Herbal Juice, Juices, Soups & Soft Drinks, Beverages Mixes, Aloe Vera Cosmetics, Aloe Vera Gel, Hand Sanitizers & Personal Hygiene, Face Wash.
Who are the key members and board of directors at Nice Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdeep Singh  | Director | 03-Sep-2009 | Current |
| Simmi Gujral | Director | 03-Sep-2009 | Current |
Financial Performance of Nice Pharmaceuticals.
Nice Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.02% decrease. The company also saw a slight improvement in profitability, with a 0.06% increase in profit. The company's net worth Soared by an impressive increase of 22.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nice Pharmaceuticals?
In 2023, Nice Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Jun 2024 | ₹2.29 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 09 Mar 2015 | ₹9.00 M | Open |
Indian Overseas Bank Creation Date: 28 Jan 2011 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Nice Pharmaceuticals?
Unlock and access historical data on people associated with Nice Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nice Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nice Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
